14 in intravenous administration of the alpha2 antagonist idazoxan in healthy volunteers. J Clin Psychopharmacol 2004; 24: 150-154. 58. Permoda-Osip A, Rybakowski JK, Suwalska A, Dmitrzak-Węglarz M, Skibińska M, Czerski P i wsp. Polimorfizm genu katechol-O-metylotransferazy (COMT) a działanie profilaktyczne litu w chorobie afektywnej dwubiegunowej. Farmakoter Psychiat Neurol 2008; 1: 19-24. 59. Permoda-Osip A, Rybakowski JK, Suwalska A, Dmitrzak-Węglarz M, Czerski P, Leszczyńska-Rodziewicz A i wsp. Polimorfizm genu transportera noradrenaliny a działanie profilaktyczne litu w chorobie afektywnej dwubiegunowej. Farmakoter Psychiat Neurol 2005; 4: 355-361. 60. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 1999; 286 (5448): 2358-2361. 61. Rimon R, Halonen P, Anttinen E, Evola K. Complement fixing antibody to herpes simplex virus in patients with psychotic depression. Dis Nerv Syst 1971; 32 (12): 822-824. 62. Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Linnoila M i wsp. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 1999; 4 (4): 360-368. 63. Rybakowski JK. Two generations of mood stabilizers [letter]. Int J Neuropsychopharmacol 2007; 10: 709-711. 64. Rybakowski JK. Aripiprazole joins the family of second-generation mood stabilizers [letter]. J Clin Psychiatry 2008; 69, 5: 862-863. 65. Rybakowski JK, Amsterdam JD. Lithium prophylaxis and recurrent labial herpes infections. Lithium 1991; 2: 43-47. 66. Rybakowski JK, Amsterdam JD, Prystowsky MD. Blood cell indicess in affective patients during lithium prophylaxis. Lithium 1993; 4: 205-209. 67. Rybakowski J, Chlopocka M, Kapelski Z, Hernacke B, Szajnerman Z, Kasprzak K. Red blood cell lithium index in patients with affective disorders in the course of lithium prophylaxis. International Pharmacopsychiatry 1974; 9: 166-171. 68. Rybakowski JK, Chłopocka M, Lisowska J, Czerwiński A. Badanie skuteczności węglanu litu w endogennych zespołach depresyjnych. Psychiatr Pol 1974; 8: 129-135. 69. Rybakowski JK, Dmitrzak-Węglarz M, Suwalska A, Leszczyńska-Rodziewicz A, Hauser J. Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder. Pharmacopsychiatry 2008 (w druku). 70. Rybakowski JK, Lehmann W. Decreased activity of erythrocyte membrane ATPases in depression and schizophrenia. Neuropsychobiology 1994; 30 (1): 11-14. 71. Rybakowski JK, Matkowski K. Synergistyczne działanie litu i tymoleptyków w depresji endogennej. Psychiatr Pol 1987; 21: 115-120. 72. Rybakowski J, Potok E, Strzyżewski W, Chłopocka-Woźniak M. The effects of lithium treatment on cation transport processes in erythrocytes of patients with affective illnesses. Pol J Pharmacol Pharm 1983; 35 (3): 209-215. 73. Rybakowski J, Strzyżewski W. Red blood cell lithium index and long term maintenance treatment. Lancet 1976; 1: 1408-1409. 74. Rybakowski JK, Strzyżewski W, Żelechowska-Ruda E, Chłopocka-Woźniak M. Labial herpes in patients with affective disorders receiving long-term lithium carbonate. Pol Tyg Lek 1993; 1-8, 48 (9-10): 215-217. 75. Rybakowski JK, Suwalska A, Czerski P, Dmitrzak-Węglarz M, Leszczyńska-Rodziewicz A, Hauser J. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacol Rep 2005; 57 (1): 124-127. 76. Rybakowski JK, Suwalska A, Skibińska M, Szczepankiewicz A, Leszczyńska-Rodziewicz A, Permoda A i wsp. Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsych 2005; 38: 166-170. AGNIESZKA PERMODA-OSIP, JANUSZ RYBAKOWSKI 77. Sastre E, Nicolay A, Bruguerolle B, Portugal H. Effect of lithium on norepinephrine metabolic pathways. Life Sci 2005; 77: 758-767. 78. Schleifer SJ, Keller SE, Meyerson AT, Raskin MJ, Davis KL, Stein M. Lymphocyte function in major depressive disorder. Arch Gen Psychiatry 1984; 41 (5): 484-486. 79. Serretti A, Lilli R, Lorenzi C, Gasperini M, Smeraldi E. Tryptophan hydroxylase gene and response to lithium prophylaxis in mmod disorders. J Psychiatr Res 1999b; 33: 371-377. 80. Serretti A, Lilli R, Mandelli L, Lorenzi C, Smeraldi E. Serotonin transporter gene associated with lithium prophylaxis in mood disorders. Pharmacogenomics J 2001; 1 (1): 71-77. 81. Shaltiel G, Maeng S, Malkesman O, Pearson B, Schloesser RJ, Tragon T i wsp. Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania. Mol Psychiatry 2008; 11. 82. Shibuya-Tayoshi S, Tayoshi S, Sumitani S, Ueno S, Harada M, Ohmori T. Lithium effects on brain glutamatergic and GA- BAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 2008 1; 32 (1): 249-256. 83. Skinner GR, Hartley C, Buchan A, Harper L, Gallimore P. The effect of lithium chloride on the replication of herpes simplex virus. Med Microbiol Immunol 1980; 168 (2): 139- 148. 84. Służewska A, Rybakowski JK, Sobieska M, Wiktorowicz K. Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depressive disorder. J Affect Disord 1996; 8, 39 (2): 149-155. 85. Służewska A, Sobieska M, Rybakowski JK. Changes in acutephase proteins during lithium potentiation of antidepressants in refractory depression. Neuropsychobiology 1997; 35 (3): 123-127. 86. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol 1996; 1, 6 (12): 1664-1668. 87. Stallone F, Shelley E, Mendlewicz J, Fieve RR. The use of lithium in affective disorders. A double-blind study of prophylaxis in bipolar illness. Am J Psychiatry 1973; 130: 1006-1010. 88. Steen VM, Gulbrandsen AK, Eiken HG, Berle JO. Lack of genetic variation in the coding region of the myo-inositol monophosphatase gene in lithium-treated patients with manic depressive illness. Pharmacogenetics 1996; 6 (1): 113-116. 89. Suwalska A, Rybakowski JK, Dmitrzak-Węglarz M, Czerski P, Skibińska M, Leszczyńska-Rodziewicz A i wsp. Działanie profilaktyczne litu w chorobie afektywnej dwubiegunowej a polimorfizmy genów receptorów dopaminergicznych typu 2. Farmakoter Psychiat Neurol 2006; 2: 79-85. 90. Szczepankiewicz A, Rybakowski JK, Skibińska M, Dmitrzak- Węglarz M, Leszczyńska-Rodziewicz A, Wilkość M i wsp. FYN kinase gene: another glutamatergic gene associated with bipolar disorder Prog Neuropsychopharmacol Biol Psych 2008 (w druku). 91. Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibińska M, Leszczyńska-Rodziewicz A, Dmitrzak-Węglarz M i wsp. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry 2006; 7 (3): 158-161. 92. Szczepankiewicz A, Skibińska M, Rybakowski JK, Suwalska A, Leszczyńska-Rodziewicz A, Tomaszewska M i wsp. Lack of association of three GRIN2B polymorphisms with bipolar disorder and lithium response. World J Biol Psychiatry 2008 (w druku). 93. Szczepankiewicz A, Skibińska M, Suwalska A, Hauser J, Rybakowski JK. The study of association of three FYN polymorphisms with prophylactic lithium response in bipolar patients. Pharmacol Rep 2008 (w druku). 94. Tajes M, Gutierrez-Cuesta J, Folch J, Ferrer I, Caballero B, Smith MA i wsp. Lithium treatment decreases activities of
BIOLOGICZNE MECHANIZMY DZIAŁANIA LITU W KONTEKŚCIE EFEKTU NORMOTYMICZNEGO 15 tau kinases in a murine model of senescence. J Neuropathol Exp Neurol 2008; 67 (6): 612-623. 95. Turecki G, Grof P, Cavazzoni P, Duffy A, Grof E, Ahrens B i wsp. Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder. Mol Psychiatry 1998; 3: 534-538. 96. Turecki G, Zhu Z, Tzenova J, Lesage A, Séguin M, Tousignant M i wsp. TPH and suicidal behavior: a study in suicide completers. Mol Psychiatry 2001; 6 (1): 98-102. 97. Wei H, Qin ZH, Senatorov VV, Wei W, Wang Y, Qian Y i wsp. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington’s disease. Neuroscience 2001; 106 (3): 603-612. 98. Williams RS, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature 2002; 16, 417 (6886): 292-295. 99. Yoshikawa T, Padigaru M, Karkera JD, Sharma M, Berrettini WH, Esterling LE i wsp. Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2). Mol Psychiatry 2000; 5 (2): 165-171. 100. Ziaie Z, Brinker JM, Kefalides NA. Lithium chloride suppresses the synthesis of messenger RNA for infected cell protein-4 and viral deoxyribonucleic acid polymerase in herpes simplex virus-1 infected endothelial cells. Lab Invest 1994; 70 (1): 29-38. Adres korespondencyjny: Klinika <strong>Psychiatrii</strong> Dorosłych Uniwersytetu Medycznego ul. Szpitalna 27/33 60-572 Poznań tel. 061 8475087, fax. 061 8480392, E-mail autora korespondującego: a.a.p@wp.pl
Change language